Physician

Internal Medicine

Aili Lazaar works in the field of Internal Medicine. He studied medicine at NYU School of Medicine. Aili Lazaar has written publications. He has 29 publications published with PubMed. The lastest publication is: 'CD40-mediated signal transduction in human airway smooth muscle.' He accepts Medicare payments and is registered with Medicare.gov.

Publications

---

• Specificity of human anti-variable heavy (VH ) chain autoantibodies and impact on the design and clinical testing of a VH domain antibody antagonist of tumour necrosis...
• The pharmacokinetics of conventional and bioenhanced tablet formulations of danirixin (GSK1325756) following oral administration in healthy, elderly, human volunteers.
• No TWEAK for COPD.
• Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis.
• Elevated airway purines in COPD.
• SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans.
• Adhesion of T-cells to airway smooth muscle cells.
• The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in Asthma.
• Airway smooth muscle as a regulator of immune responses and bronchomotor tone.
• Airway smooth muscle: a modulator of airway remodeling in Asthma.
• Is airway remodeling clinically relevant in Asthma?
• Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent.
• Technology evaluation: omalizumab, Genentech/Novartis/Tanox.
• IFN-gamma inhibits human airway smooth muscle cell proliferation by modulating the E2F-1/Rb pathway.
• Airway smooth muscle: new targets for Asthma pharmacotherapy.
• Mast cell chymase modifies cell-matrix interactions and inhibits mitogen-induced proliferation of human airway smooth muscle cells.
• Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists.
• Airway smooth muscle as an immunomodulatory cell: a new target for pharmacotherapy?
• VCAM-1 activates phosphatidylinositol 3-kinase and induces p120Cbl phosphorylation in human airway smooth muscle cells.
• Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. Modulation by cyclic adenosine monophosphate.
• Activation of p55 tumor necrosis factor-alpha receptor-1 coupled to tumor necrosis factor receptor-associated factor 2 stimulates intercellular adhesion molecule-1 exp...
• Up-regulation of ICAM-1 by cytokines in human tracheal smooth muscle cells involves an NF-kappa B-dependent signaling pathway that is only partially sensitive to dexam...
• CD40-mediated signal transduction in human airway smooth muscle.
• Antigen receptor-stimulated peripheral blood and bronchoalveolar lavage-derived T cells induce MHC class II and ICAM-1 expression on human airway smooth muscle.
• Activation of cAMP-dependent pathways in human airway smooth muscle cells inhibits TNF-alpha-induced ICAM-1 and VCAM-1 expression and T lymphocyte adhesion.
• Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain.
• T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis.
• Regulation of Tn5 by the right-repeat proteins: control at the level of the transposition reaction?

Schools

---

• New York University School Of Medicine

• Boston City Hospital

• Hospital Of The University Of Pennsylvania

Conditions Treated

---

• Asthma
• Bronchiectasis
• COPD (Chronic Obstructive Pulmonary Disease)
• Sleep Apnea
• View All

Doctors Specialties

---

• Critical Care Medicine
• Pulmonology
• Internal Medicine

Accepted Insurances

---

• Aetna HMO
• Choice Plus POS II
• Personal Choice PPO
• Regional Pref Network EPO
• Regional Pref Network HMO
• Regional Pref Network HMO+
• Regional Pref Network POS+
• Regional Pref Network PPO
• Blue Card PPO
• Cigna HMO
• Cigna PPO
• Great West Healthcare-Cigna PPO
• Open Access Plus
• Geisinger Health Plan
• HealthPartners
• Community Blue PPO
• Direct Access
• Horizon Blue Cross Blue Shield HMO
• Horizon Blue Cross Blue Shield POS
• Horizon Blue Cross Blue Shield PPO
• Choice Care PPO
• Keystone Health Plan East HMO
• Medicare MCR
• MultiPlan PPO
• Freedom Plan
• QualCare HMO
• QualCare PPO
• Navigate POS
• Options PPO
• Oxford Liberty
• United Healthcare

Education

---

• University of Pennsylvania Health System
• Boston University Medical Center
• NYU School of Medicine

Hospital

---

• Hospital of the University of Pennsylvania
• Penn Presbyterian Medical Center

Drug Facts

---

NPI NUMBER		1962516732
NPPES Provider LastName		LAZAAR
NPPES Provider FirstName		AILI
NPPES Provider ZIPCode		191044206
NPPES Provider State		PA
Specialty Description		Pulmonary Disease
Total Claim Count		222.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1962516732
Last Name Of The Provider	LAZAAR
First Name Of The Provider	AILI
View All

Similar Doctors

---

	Dr. Kamran U. Qureshi, MD
	Dr. Leejoe K. Pallickal, MD This Doctor is OpenDoctor Recommended.
	Dr. David A. Lipson, MD This Doctor is OpenDoctor Recommended.
	Dr. Steven K. Goldberg, MD This Doctor is OpenDoctor Recommended.
	Dr. Alexander E. Swift, MD This Doctor is OpenDoctor Recommended.
	Dr. Alan D. Haber, MD This Doctor is OpenDoctor Recommended.
	Dr. Daniel J. Parenti, DO This Doctor is OpenDoctor Recommended.
	Dr. Rodolfo I. Godinez, MD
	Dr. Horace Delisser, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Michael W. Sims, MD This Doctor is OpenDoctor Recommended.
	Dr. Shahana N. Karim, MD This Doctor is OpenDoctor Recommended.
	Dr. Emily A. Stewart, MD This Doctor is OpenDoctor Recommended.
	Dr. Katherine D. Sherif, MD This Doctor is OpenDoctor Recommended.
	Dr. Howard A. Miller, MD This Doctor is OpenDoctor Recommended.
	Dr. Chintana Suanlarm, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog